Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



GRAVITAS-309: Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

The purpose of this study is to assess the efficacy and safety of itacitinib in combination with corticosteroids as first-line treatment for moderate or severe chronic graft-versus-host disease (cGVHD).
Not Available
III
Jagasia, Madan
NCT03584516
VICCBMT1910

A Phase 1 Study to Evaluate SNDX- 6352 in Subjects With Active cGVHD

This is a Phase 1, Open-label, Dose Escalation study to investigate SNDX-6352 in subjects with active cGVHD.
Not Available
I
Jagasia, Madan
NCT03604692
VICCBMTP18109

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

This is a Phase 2, randomized, multicenter study to evaluate the efficacy and safety of KD025 in subjects with Chronic Graft Versus Host Disease (cGVHD) after at least 2 prior lines of systemic therapy
Not Available
II
Jagasia, Madan
NCT03640481
VICCBMT18121

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: